Synonyms
Chronic cutaneous lupus; Cutaneous only lupus; Skin lupus
Definition
Discoid lupus (DLE) is a chronic, scarring skin disease characterized by clinical, histologic, and immunopathologic findings, commonly on the face over the cheeks and bridge of the nose in a “malar” or “butterfly” distribution.
Skin disease is the second most common clinical manifestation of lupus, after joint inflammation, and is divided into acute, subacute, and chronic cutaneous forms. Of the chronic cutaneous forms, discoid lupus is the most characteristic with prominence on the face, ears, and scalp.
These “discoid” or coin-shaped lesions frequently progress to permanent scars with significant effect on the quality of life in those individuals with the disease, suggesting that prevention as well as early and efficient management towards remission be the goal of the treating physician. There are variants of DLE including the hypertrophic or lichen planus overlap form as well as the palmar/plantar or acral...
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akanase A, Reddy A, Buyon JP, Franks AG Jr, Furie RA, Kamen DL, Manzi S, Petri M, Ramsey-Goldman R, Tseng C-E, van Vollenhoven RF, Wallace DJ. Favorable Clinical Response to Belimumab at Three Months. Arthritis & Rheumatism. 2013;65(S10):S668–S668.
Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G, McGinnis K, Richardson S, Treat J, Vittorio C, Van Voorhees A, Werth VP. The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus. J Invest Dermatol. 2005;125(5):889–94.
Bastuji-Garin S, Ochonisky S, Bouche P, Gherardi RK, Duguet C, Djerradine Z, Poli F, Djerradine J, Thalidomide Neuropathy Study Group. Incidence and risk factors for thalidomide neuropathy: a prospective study of 135 dermatologic patients. J Invest Dermatol. 2002;119(5):1020–6.
Berger E, Robinson M, Patel R, Franks Jr AG. Koebner phenomenon to heat in cutaneous (discoid) lupus erythematosus (lupus ab-igne). Dermatol Online J. 2012;18(12):17.
Braunstein I, Klein R, Okawa J, Werth VP. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score. Br J Dermatol. 2012;166(5):971–5.
Chong BF, Song J, Olsen NJ. Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus. Br J Dermatol. 2012;166(1):29–35.
Costedoat-Chalumeau N, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin DL, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Tanguy ML, Hulot JS, Lechat P, Musset L, Amoura Z, Piette JC; on behalf of Group PLUS. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicenter controlled trial (PLUS Study)controlled trial (PLUS) Ann Rheum Dis. 2013;72(11):1786–92.
Cuadrado MJ, Karim Y, Sanna G, Smith E, Khamashta MA, Hughes GR. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens. Am J Med. 2005;118(3):246–50.
DeSouza A, Strober BE, Merola JF, Oliver S, Franks Jr AG. Apremilast for discoid lupus erythematosus: results of a phase 2, open-label, single-arm, pilot study. J Drugs Dermatol. 2012;11(10):1224–6.
De Souza A, Ali-Shaw T, Strober BE, Franks Jr AG. Successful treatment of subacute lupus erythematosus with ustekinumab. Arch Dermatol. 2011;147(8):896–8.
Erceg A, Bovenschen HJ, van de Kerkhof PC, et al. Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus. J Am Acad Dermatol. 2009;60:626–32.
Franks AG. Ask the experts: is the use of laser safe for people with lupus. Lupus Now. 2004;FALL:32–3.
Jabbari A, Suarez-Farinas M, Fuentes-Duculan J, Gonzalez J, Cueto I, Franks AG Jr, Krueger JG. J Invest Dermatol. 2014;134:87–95.
Järvinen TM, Hellquist A, Koskenmies S, Einarsdottir E, Panelius J, Hasan T, Julkunen H, Padyukov L, Kvarnström M, Wahren-Herlenius M, Nyberg F, D'Amato M, Kere J, Saarialho-Kere U. Polymorphisms of the ITGAM gene confer higher risk of discoid cutaneous than of systemic lupus erythematosus. PLoS One. 2010;2:5(12).
Jemec GB, Ullman S, Goodfield M, et al. A randomized controlled trial of R-salbutamol for topical treatment of discoid lupus erythematosus. Br J Dermatol. 2009;161:1365–70.
Jessop S, Whitelaw DA, Delamere FM. Drugs for discoid lupus erythematosus. Cochrane Database Syst Rev. 2009;7(4):CD002954.
Lin JH, Dutz JP, Sontheimer RD, Werth VP. Pathophysiology of cutaneous lupus erythematosus. Clin Rev Allergy Immunol. 2007;33:85–106.
Makol A, Gibson LE, Michet CJ. Successful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis. J Clin Rheumatol. 2012;18:92–5.
Merola JF, Chang CA, Sanchez MR, Prystowsky SD. Is chronic cutaneous discoid lupus protective against severe renal disease in patients with systemic lupus erythematosus? J Drugs Dermatol. 2011;10(12):1413–20.
Nabatian et al. Tumor necrosis factor a release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients. Arthritis Res Ther. 2012;14(1):R1.
Piette JC, Sbai A, Francès C. Warning: thalidomide-related thrombotic risk potentially concerns patients with lupus. Lupus. 2002;11(2):67–70.
Vasquez R, Tseng LC, Victor S, Zhang S, Chong BF. Autoantibody and clinical profiles in patients with discoid lupus and borderline systemic lupus. Arch Dermatol. 2012;148(5):651–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Franks, A.G. (2014). Discoid Lupus. In: Mackay, I.R., Rose, N.R., Diamond, B., Davidson, A. (eds) Encyclopedia of Medical Immunology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-84828-0_280
Download citation
DOI: https://doi.org/10.1007/978-0-387-84828-0_280
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-84827-3
Online ISBN: 978-0-387-84828-0
eBook Packages: MedicineReference Module Medicine